接受新生血管性年龄相关性黄斑变性治疗的亚洲患者视功能相关生活质量变化及其影响因素
这项纵向研究纳入新加坡三级眼科中心的116例新生血管性年龄相关性黄斑变性患者,评估治疗12个月后视功能相关生活质量变化。治疗后患眼最佳矫正视力平均改善近2行(-0.22±0.40 logMAR,p<0.001),43%(n=50)患者视力增益≥2行;阅读、移动和情绪评分均显著改善。多变量模型中,视力改善≥2行与阅读评分增加47%独立相关,但与移动或情绪评分无独立关联。
要点
- 治疗后患眼最佳矫正视力平均改善近2行(-0.22±0.40 logMAR,p<0.001),43%(n=50)患者视力增益≥2行。
- 阅读、移动和情绪评分分别改善0.43±1.73、0.45±1.54和0.66±1.6(p值均<0.001)。
- 视力改善≥2行与阅读评分增加47%独立相关(β=0.20;CI 0.01至0.39),但与移动或情绪评分无独立关联。
核心结论
- 近半数接受新生血管性年龄相关性黄斑变性治疗的患者报告视力改善2行,进而与阅读评分显著正性增加相关。
- 移动和情绪评分的改善似乎由视力以外的因素驱动。
研究设计与样本
- 纵向研究,从新加坡一家三级眼科中心招募116例接受新生血管性年龄相关性黄斑变性治疗的患者(平均年龄±标准差=66.5±9.9岁;59.5%为男性)。
- 在基线和第12个月评估最佳矫正视力和视功能损害影响问卷,主要结局为Rasch衍生的阅读、移动和情绪评分。
- 采用多变量线性回归分析社会人口学、临床和治疗相关因素对视功能相关生活质量变化的影响。
主要发现
- 治疗后患眼最佳矫正视力平均改善近2行(-0.22±0.40 logMAR,p<0.001),43%(n=50)患者报告最佳矫正视力增益≥2行。
- 阅读、移动和情绪评分的平均±标准差变化分别为0.43±1.73、0.45±1.54和0.66±1.6(p值均<0.001)。
- 多变量模型中,最佳矫正视力改善≥2行与阅读评分增加47%独立相关(β=0.20;CI 0.01至0.39),但与移动或情绪评分无独立关联。
关键数值与推荐
- 最佳矫正视力变化分为三类:增益≥2行;无变化;丢失≥2行。
- 阅读、移动和情绪评分采用Rasch衍生的视功能损害影响问卷评分。
- 最佳矫正视力改善≥2行与阅读评分增加47%独立相关(β=0.20;CI 0.01至0.39)。
临床怎么用
- 原文未据此给出推荐。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
AIM: To assess the change in vision-related quality of life (VRQoL) after treatment for neovascular age-related macular degeneration (nAMD) and factors influencing this change in an Asian population. METHODS: In this longitudinal study, 116 patients (mean age±SD=66.5±9.9 years; 59.5% male) who underwent treatment for nAMD were recruited from a tertiary eye centre in Singapore. Best-corrected visual acuity (BCVA) and the Impact of Vision Impairment (IVI) questionnaire were evaluated at baseline and month 12. We defined three categories of BCVA change in the treated eye: BCVA gain ≥2 lines; no change in BCVA; BCVA loss ≥2 lines. The main outcome measures were the Rasch-derived IVI Reading, Mobility, and Emotional Scores. Multivariable linear regression analyses assessed the influence of sociodemographic, clinical and treatment-related factors on change in VRQoL. RESULTS: Following treatment, mean treated-eye BCVA improved by almost 2 lines (-0.22±0.40 logMAR, p<0.001) and 43% (n=50) patients reported a gain in BCVA of ≥2 lines. Mean±SD scores for Reading, Mobility and Emotional demonstrated positive changes of 0.43±1.73, 0.45±1.54 and 0.66±1.6, respectively (p<0.001 for all). In multivariable models, a ≥2 line improvement in BCVA was independently associated with a 47% (β=0.20; CI 0.01 to 0.39) increase in Reading Scores, but was not independently associated with Mobility or Emotional Scores. CONCLUSION: Nearly half of patients undergoing treatment for nAMD reported a 2-line improvement in vision which was, in turn, associated with substantial positive increases in Reading Scores. Improvements in Mobility and Emotional Scores appear to be driven by factors other than visual acuity.
引用
- Fenwick EK, Cheung GCM, Gan AT, et al. Change in vision-related quality of life and influencing factors in Asians receiving treatment for neovascular age-related macular degeneration. Br J Ophthalmol. 2017. PMID: 28659392. doi:10.1136/bjophthalmol-2017-310532
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。